Archive for Author: Afsaneh Naimollah

Mar 27, 2018

HIMSS 2018: The Not-So-Obvious Takeaways. Our March HIT Market Update

Healthcare IT, Healthcare Newsletter, Market Update, Newsletter 0 Comments

Dear Clients and Friends, Click here to see the full HIT Market Update including Capital Raise and M&A transactions. Earlier this month, we joined the 45,000 healthcare enthusiasts at HIMSS in Las Vegas. Rather than covering the obvious themes of interoperability, blockchains or the cloud, here are some of our not-so-obvious key takeaways. The tech giants had many representatives who flew undercover – Apple had no booth. Amazon’s booth was not labeled Amazon, but “AWS”, their cloud platform. Google’s messaging was somewhat opaque. Despite the secrecy, these companies appear intent to bring the Silicon Valley innovation culture to healthcare. We…

Read More

Feb 27, 2018

What Does Healthcare Have In Store for 2018 – Part II? Here Are Our Predictions.

Healthcare IT, Healthcare Newsletter, Market Update, Newsletter 0 Comments

Dear Clients and Friends, Read more from our February 2018 HIT Market Update here. Last month we shared Part I of our predictions for the New Year covering new risk models, EMR as a platform, and blockchains as the new infrastructure. Here is Part II of our outlook for the year. Valuations of mid to late stage companies could see lower altitudes. Even though 2017 was a banner year for digital health funding at a record $5.8 billion, in many ways, it fell short of expectations. There were no IPOs in the digital health space in 2017, and M&A volume…

Read More

Jan 21, 2018

What Does Healthcare Have In Store for 2018? Here Are Our Predictions.

Healthcare IT, Healthcare Newsletter, Market Update, Newsletter 0 Comments

Dear Clients and Friends, Read more from our January 2018 HIT Market Update here. Once again it is time to try our hand at predicting the trends that will shape the course of the New Year. Here is our Part I. A different approach to risk management will drive the largest partnerships and M&A transactions. The pending CVS/Aetna and Humana/Kindred acquisitions are not about reducing duplicate costs or adding customers to increase scale. They are about the need to offer a more complete service. The argument is that control over value chain will translate into a more efficient organization with…

Read More

Oct 31, 2017

Is Bioelectronic Medicine the Next, Next Thing for Big Pharma?

Healthcare IT, Healthcare Newsletter 0 Comments

Dear Clients and Friends, Please click here for our October HIT Market Update. According to PhRMS, it takes 10 years and $2.6 billion to bring a drug to market and only two out of ten approved medications produce revenues that exceed their R&D costs. Many expect the picture to worsen in the coming years. Perhaps it is time to invest less in chemical engineering and pay more attention to bioelectronic medicines. The vision for bioelectronic medicines is one of miniature, implantable devices that can be attached to individual peripheral nerves. The nervous system is essentially the body’s electrical and communication systems that…

Read More

Sep 29, 2017

What are data crunchers missing in healthcare? Our September 2017 HIT Market Update

Healthcare IT, Healthcare Newsletter, Market Update, Newsletter 0 Comments

Dear Clients and Friends, Please click here for our September HIT Market Update. There is a saying that “In God we trust… but all others must bring data”. We agree. Without data, we trust no one. And we want analytics too. But even that is not always enough because those who crunch data in healthcare sometimes cannot deliver contextual precision. Here are a few examples: Population health management systems are focusing on the wrong population – Data analytics companies strive to identify that segment of the population that consumes the most $$. The concept is logical – crafting tailor made…

Read More

Back to Top